Evidence map›Paper›PMID 35749350›Full record

Trial reportPloS one2022

Radiomics for identifying lung adenocarcinomas with predominant lepidic growth manifesting as large pure ground-glass nodules on CT images.

Ziqi Xiong, Yining Jiang, Di Tian, Jingyu Zhang, Yan Guo, Guosheng Li, Dongxue Qin, Zhiyong Li

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. PreoperativeComputational and structural biotechnology journal · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ziqi XiongDepartment of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Yining JiangDepartment of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Di TianDepartment of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Jingyu ZhangDepartment of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Yan GuoGE Healthcare, Beijing, China.
Guosheng LiDepartment of Pathology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Dongxue QinDepartment of Radiology, the Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Zhiyong LiDepartment of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.ORCID 0000-0002-3820-1460
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo explore the value of radiomics in the identification of lung adenocarcinomas with predominant lepidic growth in pure ground-glass nodules (pGGNs) larger than 10 mm.

methodsWe retrospectively analyzed CT images of 204 patients with large pGGNs (≥ 10 mm) pathologically diagnosed as minimally invasive adenocarcinomas (MIAs), lepidic predominant adenocarcinomas (LPAs), and non-lepidic predominant adenocarcinomas (NLPAs). All pGGNs in the two groups (MIA/LPA and NLPA) were randomly divided into training and test cohorts. Forty-seven patients from another center formed the external validation cohort. Baseline features, including clinical data and CT morphological and quantitative parameters, were collected to establish a baseline model. The radiomics model was built with the optimal radiomics features. The combined model was developed using the rad_score and independent baseline predictors. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC) and compared using the DeLong test. The differential diagnosis performance of the models was compared with three radiologists (with 20+, 10+, and 3 years of experience) in the test cohort.

resultsThe radiomics (training AUC: 0.833; test AUC: 0.804; and external validation AUC: 0.792) and combined (AUC: 0.849, 0.820, and 0.775, respectively) models performed better for discriminating than the baseline model (AUC: 0.756, 0.762, and 0.725, respectively) developed by tumor location and mean CT value of the whole nodule. The DeLong test showed that the AUCs of the combined and radiomics models were significantly increased in the training cohort. The highest AUC value of the radiologists was 0.600.

conclusionThe application of CT radiomics improved the identification performance of lung adenocarcinomas with predominant lepidic growth appearing as pGGNs larger than 10 mm.

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsHumansNeoplasm InvasivenessRetrospective StudiesTomography, X-Ray Computed

Identifiers

PMID35749350
PMCPMC9231804
OpenAlexW4283465304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.